Comparison of the therapeutic indexes of different molecular forms of botulinum toxin type A
- 31 January 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 508 (1-3) , 223-229
- https://doi.org/10.1016/j.ejphar.2004.12.007
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxinJournal of Medical Microbiology, 2002
- Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safetyToxicon, 2002
- A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in miceToxicon, 2001
- Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1)Microbiology, 1999
- The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxinMicrobiology, 1997
- Blepharospasm and Hemifacial SpasmOphthalmology, 1997
- Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effectsSurvey of Ophthalmology, 1996
- Response and immunoresistance to botulinum toxin injectionsNeurology, 1995
- Measurement of Botulinum Toxin Activity: Evaluation of the Lethality AssayToxicology and Applied Pharmacology, 1994
- Botulinum Toxin: Mechanism of Presynaptic BlockadeScience, 1976